Abraxane inventor buys follow-on version of drug from Sorrento
This article was originally published in Scrip
Executive Summary
In a possible act of nostalgia, NantPharma – a company founded by Abraxane inventor Dr Patrick Soon-Shiong – has picked up a next generation version of the chemotherapy product from Sorrento Therapeutics, in a deal worth a potential $1.3bn.